Finally, the combination of 68Ga-PSMA PET/CT and mpMRI demonstrated a higher diagnostic accuracy than either modality alone for detecting clinically significant PCa, with a sensitivity of 89%, specificity of 96%, and overall accuracy of 96% [17]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.